• 제목/요약/키워드: Viral hepatitis

검색결과 298건 처리시간 0.031초

An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus

  • Kim, Do-Hyoung;Ni, Yi;Lee, Si-Hyung;Urban, Stephan;Han, Kyou-Hoon
    • BMB Reports
    • /
    • 제41권9호
    • /
    • pp.640-644
    • /
    • 2008
  • The preS1 surface protein of the hepatitis B virus (HBV) is a key factor involved in initial viral entry into hepatocytes. It has been long postulated that an anti-HBV effect should be achievable using peptide fragments of the preS1. Recent reports demonstrated that several preS1-derived lipo-peptides in genotype D HBV exhibit nano to picomolar inhibitory activity against HBV infection. In this study, an acylated analog of a preS1 fragment, a 21-residue lipo-peptide (named 7524 BVS7) with a sequence of palmitoyl-GMGTNLSVPNPLGFFPDHQLDC-$NH_2$, from genotype C HBV was produced base upon a previous structural study and was shown potently inhibits HBV infection with an $IC_{50}$ of $\approx$ 20 nM.

Nonstructural Protein 5B of Hepatitis C Virus

  • Lee, Jong-Ho;Nam, In Young;Myung, Heejoon
    • Molecules and Cells
    • /
    • 제21권3호
    • /
    • pp.330-336
    • /
    • 2006
  • Since its identification in 1989, hepatitis C virus has been the subject of extensive research. The biology of the virus and the development of antiviral drugs are closely related. The RNA polymerase activity of nonstructural protein 5B was first demonstrated in 1996. NS5B is believed to localize to the perinuclear region, forming a replicase complex with other viral proteins. It has a typical polymerase structure with thumb, palm, and finger domains encircling the active site. A de novo replication initiation mechanism has been suggested. To date, many small molecule inhibitors are known including nucleoside analogues, non-nucleoside analogues, and pyrophosphate mimics. NS5B interacts with other viral proteins such as core, NS3, 4A, 4B, and 5A. The helicase activity of NS3 seems necessary for RNA strand unwinding during replication, with other nonstructural proteins performing modulatory roles. Cellular proteins interacting with NS5B include VAMP-associated proteins, heIF4AII, hPLIC1, nucleolin, PRK2, ${\alpha}$-actinin, and p68 helicase. The interactions of NS5B with these proteins might play roles in cellular trafficking, signal transduction, and RNA polymerization, as well as the regulation of replication/translation processes.

Polyadenylation Is Dispensable for Encapsidation and Reverse Transcription of Hepatitis B viral Pregenomic RNA

  • Lee, Hye-Jin;Lee, Jehan;Shin, Myeong-Kyun;Ryu, Wang-Shick
    • Molecules and Cells
    • /
    • 제25권4호
    • /
    • pp.545-552
    • /
    • 2008
  • A hepadnaviruses replicates its DNA genome via reverse transcription of an RNA template (pregenomic RNA or pgRNA), which has a cap structure at the 5' end and a poly(A) tail at the 3' end. We have previously shown that the 5' cap is indispensable for encapsidation of the pgRNA. A speculative extension of the above finding is that the cap contributes to encapsidation via its interaction with the poly(A) tail, possibly involving eIF4E-eIF4G-PABP interaction. To test this hypothesis, poly(A)-less pgRNAs were generated via cleavage by a cis-acting hepatitis delta virus ribozyme sequence. We found that accumulation of the poly(A)-less pgRNA was markedly diminished, mostly likely due to its reduced stability. Importantly, however, the remaining poly(A)-less pgRNAs were nonetheless encapsidated and reverse transcribed normally when the reduced stability was taken account. Our finding clearly contradicts the notion that the poly(A) tail has any function in encapsidation and viral reverse transcription.

Epidemiologic Trends in Human Hepatitis A Virus Infection Stratified by Age between 2010 and 2018 in Cheonan, Korea

  • Jeon, Jae-Sik;Kim, Jae Kyung
    • 한국미생물·생명공학회지
    • /
    • 제48권4호
    • /
    • pp.564-568
    • /
    • 2020
  • Although studies on Hepatitis A virus (HAV) were crucial in the establishment of the HAV infection prevention programs, no systematic investigation into HAV has been conducted since 1999. We retrospectively analyzed the data between January 2010 to December 2018 from all the patients who underwent HAV antibody tests at the Dankook University Hospital Health Care Center. Data were collected from 56,204 individuals. Overall, 34,834 (62.0%) individuals from this cohort were positive for HAV antibodies and the annual rate of anti-HAV antibody positivity was highest in 2010 (68.5%) and lowest in 2013 (54.8%). The average decline in the antibody positivity rate was 0.62% per year, showing a statistically significant difference (p < 0.001). In the over 40s age group, anti-HAV antibody positivity rates decreased from 89% in 2010 to 64% in 2018 (p < 0.001), with an annual decrease of 3.1%. In the over 30s age group, it decreased from 48.2% in 2010 to 34.7% in 2018 (p < 0.001), with an annual decrease of 1.82%. This study shows that the antibody positivity rate is decreasing across age groups but given that HAV infection poses more significant risks in older patients it is important to expand the evaluations of the current and future antibody positivity rates for HAV in various age groups.

대장균에서 한국형 B형 간염바이러스 내면항원 유전자의 발현 (Expression of Hepatitis B Viral Core Antigen Gene in Excherichia coli)

  • 최수근;이원상;김성기;노현모
    • 미생물학회지
    • /
    • 제29권2호
    • /
    • pp.80-84
    • /
    • 1991
  • We cloned and expressed hepatitis B viral core antigen (HBcAg) gene in E. coli using $P_{L}$ promoter system. For optimal expression of the gene, we undertook the studies on the effects of the distance between Shine-Dalgarno (SD) sequence and start codon, copy number of repressor gene, induction temperature, and the stability of the core antigen. The results demonstrated that the induction at 37.deg.C was more efficient than at 42.deg.C, and the 11 base pairs (bp) distance between SD sequence and start codon of HBcAg gene was more efficient than the 15 bp distance in E. coli. The copy number of cI857 repressor gene did not influence on the expression of HBcAg, and the expression level of HBcAg in mutant type (low protease activity) and wild type strains was almost the same. The produced core antigen appeared to be HBcAg not HBeAg judged by two different radioimmunoassat (RIA) kits. This result suggested that the antigen was stable in E. coli.i.

  • PDF

Selection of Peptides Binding to HCV E2 and Inhibiting Viral Infectivity

  • Hong, Hye-Won;Lee, Seong-Wook;Myung, Hee-Joon
    • Journal of Microbiology and Biotechnology
    • /
    • 제20권12호
    • /
    • pp.1769-1771
    • /
    • 2010
  • The envelope glycoprotein E2 of hepatitis C virus (HCV) binds to various cell surface receptors for viral infection. We performed biopanning against this protein and selected peptides from phage display peptide libraries. Two short peptides, pep7-1 and pep12-1, were selected and their ability to inhibit the infection process was investigated. When pep7-1 was present, the infectivity of HCV particles in cell culture was notably decreased. This decrease was demonstrated by Western blot analysis, immunofluorescence assay, and reverse transcription PCR assay. However, pep12-1 showed little inhibitory effect on HCV infection.

Effect of Korean Red Ginseng in chronic liver disease

  • Park, Tae Young;Hong, Meegun;Sung, Hotaik;Kim, Sangyeol;Suk, Ki Tae
    • Journal of Ginseng Research
    • /
    • 제41권4호
    • /
    • pp.450-455
    • /
    • 2017
  • Chronic liver disease, one of the most common diseases, typically arises from nonalcoholic fatty liver disease, alcoholic liver disease, chronic viral hepatitis, or hepatocellular carcinoma. Therefore, there is a pressing need for improved treatment strategies. Korean Red Ginseng has been known to have positive effects on liver disease and liver function. In this paper, we summarize the current knowledge on the beneficial effects of Korean Red Ginseng on chronic liver disease, a condition encompassing nonalcoholic fatty liver disease, alcoholic liver disease, chronic viral hepatitis, and hepatocellular carcinoma, as supported by experimental evaluation and clinical investigation.

오리 간염 바이러스의 분리와 국내 분리주의 약독화 (Isolation of duck hepatitis virus and it's attenuation in chicken embryos)

  • 성환우;김재홍
    • 대한수의학회지
    • /
    • 제40권1호
    • /
    • pp.101-109
    • /
    • 2000
  • Duck viral hepatitis is an acute, highly infectious viral disease of young dacklings aged from two days to three weeks. The significant lesion associated with the disease was enlarged liver including necrotic foci and numerous hemorrhagic spots. We have isolated five strains of duck hepatitis virus (DHV) from field cases showing about 20% mortality with a sign of opisthotonos. When a-day-old ducklings were intramuscularly inoculated with one of the isolates, 92% of the birds were died within 5 days. We attempted to develop an attenuated strain of duck hepatitis virus (DHV) using one of the isolates by serial chicken embryo passages. The propagation of DHV in chicken embryos was carried 140 passages. The virus titer increased gradually from the $21^{st}$ through the $50^{th}$ passage, but there was no significant increase of virus titer in subsequent passages after then. Through the serial passages, the virulence of the virus for chicken embryos was gradually increased but decreased for ducklings. The pathogenicity of the virus for ducklings was preserved up to the $21^{st}$ passage but disappeared at the $50^{th}$passage. An attenuated Korean isolate which was passaged 140 times in chicken embryos gave good protection in ducklings against both challenge infection to a Korean virulent strain and to a DHV-DRL strain, a type 1 reference strain of DHV, which indicated that the Korean isolates could be classified as DHV type 1. And the above results suggest that an attenuated Korean isolate can be used for developing a live DHV vaccine.

  • PDF

만성 신생아 간염의 임상적 고찰: 비-가족형, 비-대사성, 비-A, B, C형 바이러스성 신생아 간염 (The Clinical Features of Chronic Neonatal Hepatitis: Non-familial, Non-metabolic and Non-A, B, C Viral Hepatitis)

  • 박지애;이창훈;박재홍
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제9권2호
    • /
    • pp.242-248
    • /
    • 2006
  • 목 적: 비-가족형, 비-대사성, 비-A, B, C형 바이러스성 신생아 간염은 양호한 경과를 취한다고 알려져 있지만, 장기적인 경과 관찰에 대한 연구가 부족하다. 연자들은 이 질환의 임상적 특징을 연구하여 임상 경과 및 예후 예측에 도움을 얻고자 하였다. 방 법: 1998년 1월부터 2004년 1월까지 생후 3개월 이내에 부산대학교병원에서 신생아 간염으로 진단되었던 환자 중 임상 소견 및 생화학적 검사의 이상 소견이 6개월 이상 지속되었던 34명을 대상(A, B, C형 바이러스성, 대사성, 유전성 신생아 간염은 제외)으로 하여 임상적 소견, 검사실 소견 및 조직학적 소견을 병력지와 조직 슬라이드 분석을 통해 후향적으로 연구를 시행하였다. 결 과: 성비는 2.4 : 1로 남아가 많았고, 진단 시 연령은 생후 1~2개월 사이가 가장 많았다. 혈청 ALT의 최고치의 범위는 광범위(100~1,000 IU/L)하였으나, 300 IU/L 미만이 41%였다. 혈청 직접형 빌리루빈의 최고치는 50%에서 1.0~5.0 mg/dL 사이였다. CMV에 대한 IgM 항체 검사 또는 PCR 검사에서 34%가 양성이었다. 추적 기간의 조건을 충족한 29명 중 11명(37.9%)의 환자가 1년 이내에 ALT 수치가 정상화되었고, 1년 이상 ALT 수치가 증가된 환자 13명 중에서는 2년 이내에 정상화된 경우가 9명(69.2%), 2년 이상 지속적으로 상승된 경우가 4명(30.7%)였다. 2년 이상 지속적으로 ALT 수치의 상승이 있었던 경우 간 조직 검사에서 간문맥 주변 섬유화, 간문맥 염증 및 간소엽 염증 등의 변화가 2년 이내에 회복된 경우보다 심했으나 통계학적인 의미는 없었다. 결 론: 비-가족형, 비-대사성, 비-A, B, C형 바이러스성 신생아 간염은 비교적 예후가 양호하지만 혈청 ALT 수치의 상승이 1년 이상 지속 시 간 손상의 정도에 대한 평가와 만성 간질환에 대한 주의 깊은 관찰이 필요하다.

  • PDF

간기능 검사상 이상을 보인 환자에서의 HBV 표식자 발현 양상 (A Clinical Study of HBV Markers in Various Liver Diseases Carriers and Controls)

  • 최정규;이용원;최진명;정문관;이헌주;김종설
    • Journal of Yeungnam Medical Science
    • /
    • 제2권1호
    • /
    • pp.211-220
    • /
    • 1985
  • 저자들은 급성간염 39예, 만성간염 79예, 간경변증 30예, 원발성간암 16예, 보유자 14예 및 비교군 129예의 모두 307명을 대상으로 하여 SGOT, SGPT 및 HBV 표식자를 조사하여 다음의 결과를 얻었다. 1. HBsAg의 발현율은 급성간염의 66.7%, 만성간염의 63.3%, 간경변증의 36.7%, 원발성간암의 81.3% 및 비교군에서 27.1%인 것으로 나타났다. 2. AntiHBc의 발현율은 급성간염의 0%, 만성간염의 21.5%, 간경변증의 36.7%, 원발성간암의 31.3%, 보유자의 0% 및 비교군에서 44.2%로 나타났다. 3. HBeAg은 만성간질환중 만성간염에서 45.6%로 가장 높게 나타났고 AntiHBe는 원발성간암에서 56.3%로 가장 높았다. 4. AntiHBc는 각종 간질환, 보유자 및 비교군에서 높게 나타났으며 이는 AntiHBc자체는 간질환에 직접 관계가 없는 감염의 흔적으로 생각된다. 5. HBsAg 보유자 14명중 6명(42.3%)에서 혈청 GOT, SPT 치의 이상 상승이 있었다. 6. HBV에 감염된 혈청학적 증거가 있으면서 간기능에 이상이 있을 때, HBV 이외에 non-A, non-B 바이러스, Delta agent 또는 타 바이러스나 관련된 다른 요인과의 관계가 있을 수 있는 점을 고려하여야 할 것으로 생각된다. HBV의 5 가지 표식 자가 모두 음성으로 나타난 환자는 급성간염의 5.1%, 만성간염의 5.1%에 달했으며, 이것은 HBV 이외의 다른 원인이 병인이 될 수 있음을 시사하며 비교군 중 SGOT, SGPT치의 증가를 보인 군에서는 17.6%, 정상 SGOT, SGPT치를 나타낸 군에서는 12.8%에서 모든 HBV 표식자가 음성으로 나타났다.

  • PDF